삼성바이오로직스

207940KOSPI

57.8 / 100

Reference Date: 2026-09-08

Financial Score24.0 / 40

News Sentiment16.8 / 25

Momentum8.0 / 20

Disclosure9.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Declined 5.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Samsung BioLogics is a global CDMO (Contract Development and Manufacturing Organization) providing biopharmaceutical contract manufacturing and development services. In 2025, it restructured into a pure-play CDMO business by spinning off Samsung Epics Holdings. The company generates significant revenue from Europe and the U.S. and is expanding into next-generation biopharmaceuticals such as mRNA, ADC, and cell/gene therapies.

Number of Employees

10,910people

Average Salary

114.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

38.03Industry Average 15.000.0Point

2.5x industry avg (risky)

PBR

9.11Industry Average 1.200.0Point

7.6x industry avg (risky)

ROE

19.44Industry Average 8.007.0Point

2.4x industry avg (excellent)

Debt Ratio

14.45Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20259.0 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲11.6% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲37.6% (2-year basis)

ROE Trend

3.5 / 4

Avg ROE 13.0% (improving, 3yr)

Detailed News Sentiment

73 totalPositive 33Neutral 29Negative 11Average Sentiment Score 67.3

Positive
“더 뽑을 여력” 이재용 약속대로…삼성 공채
삼성바이오로직스의 공채 확대는 기업의 인재 확보 의지를 보여주며, 긍정적인 고용 환경 조성으로 주가 상승 기대.
Negative
삼성전자 넘치는 현금…바이오 증자 불렀나 [재계톡톡]
삼성바이오로직스의 대규모 유상증자 결정이 시장에서 부정적인 반응을 불러일으키고 있다.
Neutral
한화·신세계도 쪼갠다…대기업 사업재편 우회로로 뜨는 인적분할
기업들의 지배구조 개편을 위한 인적분할 논의가 있으나, 삼성바이오로직스에 직접적인 영향은 제한적이다.

Detailed Momentum

52-week position3.0Point

52w lower range (27%)

Current 1,466,000Won52-week high 1,965,00052-week low 1,273,000

1-month return2.0Point

1m -5.78% (slight drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

11 totalPositive 1Neutral 9Negative 1

Neutral최대주주등소유주식변동신고서2026-09-07
Neutral[기재정정]기업설명회(IR)개최(안내공시)2026-09-03
Neutral대규모기업집단현황공시[분기별공시(개별회사용)]2026-08-31
Neutral타법인주식및출자증권취득결정(종속회사의주요경영사항)2026-08-31
Neutral주주명부폐쇄기간또는기준일설정2026-08-28